CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia.
Saved in:
| Title: | CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia. |
|---|---|
| Authors: | Xu J; Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Department of Internal Medicine, Stanford University, Stanford, CA., McCoy M; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Martinez Z; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Sussman JH; Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Gao D; Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Vincent T; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Wang H; Department of Internal Medicine, Stanford University, Stanford, CA., Ma C; Department of Internal Medicine, Stanford University, Stanford, CA., Elghawy O; Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Chen GM; Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Yang AG; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Pölönen P; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN., Natan K; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Shraim R; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Newman H; Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Hofmann TJ; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Scoma S; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., DiNofia AM; Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Hunger SP; Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Yang JJ; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN., Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN., Bernt KM; Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Hexner EO; Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Grupp SA; Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Watanabe K; Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., June CH; Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA., Tan K; Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA.; Center for Single Cell Biology, Children's Hospital of Philadelphia, Philadelphia, PA., Teachey DT; Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Diorio C; Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA. |
| Source: | Blood advances [Blood Adv] 2026 Apr 28; Vol. 10 (8), pp. 2676-2686. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
